News

Takeda Secures Landmark Approval for Orzeyful in China | iPharmaCenter

Badari Andukuri

7 hours ago

Top 10 pharmaceutical companies by revenues in 2026 | Official Figures | iPharmaCenter

Badari Andukuri

10 hours ago

FDA Approves Jideytro for Previously Treated ROS1 Positive Non Small Cell Lung Cancer

Badari Andukuri

1 day ago

Top 10 U.S. healthcare companies by 2026 revenue | iPharmaCenter

Badari Andukuri

2 days ago

India's CDSCO Grants Regulatory Approval for Takeda’s Qdenga Dengue Vaccine

Badari Andukuri

3 days ago

CMS Outlines Operational Path for 2028 Maximum Fair Price Compliance

Badari Andukuri

3 days ago

CMS Targets Fee-for-Service Fragmentation in New 2027 Policy Roadmap

Badari Andukuri

4 days ago

American Academy of Dermatology (AAD) Innovation Academy 2026

Badari Andukuri

7 days ago

Eli Lilly to Acquire AtaiBeckley for Up to $3.8 Billion, Expanding Psychedelic Neuroscience Pipeline

Badari Andukuri

Jul 16

European Commission Grants Approval for Oral Semaglutide in Weight Management

Badari Andukuri

Jul 16

Aetna Survey Highlights Evolving Payer-Provider Confidence Landscape | iPharmaCenter

Badari Andukuri

Jul 15

FDA Grants Landmark Approval for REVTORPYK: A New Standard for PIK3CA Wild-Type Breast Cancer

Badari Andukuri

Jul 15

CMS Proposes Major Medicare Overhaul: Shifting Toward Accountable Care and Value-Based Payments

Badari Andukuri

Jul 15

Germany Enacts 2026 Healthcare Reform to Curb Statutory Insurance Spending

Badari Andukuri

Jul 14

AstraZeneca Bolsters Oncology Pipeline with Global Acquisition of Zegfrovy

Badari Andukuri

Jul 14

FDA Approval of Sarclisa Escena Marks Shift Toward Subcutaneous Oncology Delivery | iPharmaCenter

Badari Andukuri

Jul 14

Navigating the Shift: Employer-Led Demands Reshape Pharmacy Benefit Management

Badari Andukuri

Jul 11

FDA Approves KEYTRUDA-Padcev Combo as First Perioperative Standard for Muscle-Invasive Bladder Cancer

Badari Andukuri

Jul 11

CMS 2027 Overhaul: Restructuring the Economics of Outpatient Care

Badari Andukuri

Jul 10

Vertex moves to buy Crinetics in $10 billion endocrinology deal | iPharmaCenter

Badari Andukuri

Jul 9

Takeda Secures Landmark Approval for Orzeyful in China | iPharmaCenter

Top 10 pharmaceutical companies by revenues in 2026 | Official Figures | iPharmaCenter

FDA Approves Jideytro for Previously Treated ROS1 Positive Non Small Cell Lung Cancer

Top 10 U.S. healthcare companies by 2026 revenue | iPharmaCenter

India's CDSCO Grants Regulatory Approval for Takeda’s Qdenga Dengue Vaccine

CMS Outlines Operational Path for 2028 Maximum Fair Price Compliance

CMS Targets Fee-for-Service Fragmentation in New 2027 Policy Roadmap

American Academy of Dermatology (AAD) Innovation Academy 2026

Eli Lilly to Acquire AtaiBeckley for Up to $3.8 Billion, Expanding Psychedelic Neuroscience Pipeline

European Commission Grants Approval for Oral Semaglutide in Weight Management

Aetna Survey Highlights Evolving Payer-Provider Confidence Landscape | iPharmaCenter

FDA Grants Landmark Approval for REVTORPYK: A New Standard for PIK3CA Wild-Type Breast Cancer

CMS Proposes Major Medicare Overhaul: Shifting Toward Accountable Care and Value-Based Payments

Germany Enacts 2026 Healthcare Reform to Curb Statutory Insurance Spending

AstraZeneca Bolsters Oncology Pipeline with Global Acquisition of Zegfrovy

FDA Approval of Sarclisa Escena Marks Shift Toward Subcutaneous Oncology Delivery | iPharmaCenter

Navigating the Shift: Employer-Led Demands Reshape Pharmacy Benefit Management

FDA Approves KEYTRUDA-Padcev Combo as First Perioperative Standard for Muscle-Invasive Bladder Cancer

CMS 2027 Overhaul: Restructuring the Economics of Outpatient Care

Vertex moves to buy Crinetics in $10 billion endocrinology deal | iPharmaCenter

Join our mailing list